External Expert Profile
Prof. Dalia Dawoud is Associate Director (Research) at the National Institute for Health and Care Excellence (NICE). She holds a PhD in pharmaceutical policy and economics from King’s College London. Her current work is focused on advancing the methods of HTA and clinical guideline development where she is leading NICE input into European Commission funded projects, such as IMI EHDEN and HORIZON 2020 HTx, and its newly established HTA Innovation Laboratory (HTA Lab). She serves on a number of international research projects’ advisory boards and as Associate Editor of ISPOR journal Value in Health.
Dalia is a Director on ISPOR Board of Directors and was past chair of ISPOR Biosimilars Special Interest Group. She is a widely published author in the fields of pharmaceutical policy, practice, pharmacoeconomics and HTA.